Bausch + Lomb is moving beyond eye-care products with an AI platform built around the patient journey
Bausch + Lomb’s Orphia brings AI to cataract education, but adoption will depend on workflow integration, validation, privacy and trust.
Medical Devices & Diagnostics
Medical Devices & Diagnostics
What iHealthScreen’s iPredict-DR clearance changes for diabetes clinics and primary care
iHealthScreen Inc. has received U.S. Food and Drug Administration 510(k) clearance for iPredict-DR, an AI-powered Software as a Medical Device for automated diabetic retinopathy screening. The retinal imaging software detects more than mild diabetic retinopathy in adults with diabetes who have not previously been diagnosed with the condition, placing the healthcare AI developer into a
Medical Devices & Diagnostics
Why Royal Philips’ Alturion ultrasound launch matters for radiology and point-of-care imaging
Royal Philips’ Alturion ultrasound launch targets AI-powered imaging workflows as hospitals face rising scan volumes and staffing pressure.
Medical Devices & Diagnostics
Is Vilo Signal OS truly different from Oura Advisor and WHOOP’s proactive AI?
Discover how Vilo Signal OS plans to turn smart ring data into proactive health guidance, and why validation, privacy and trust will decide its future.
Medical Devices & Diagnostics
Greenstone Biosciences and Intel chase faster drug discovery as regulators back human-relevant models
Discover how Greenstone Biosciences and Intel plan to scale iPSC drug discovery, and why validation will determine the platform’s impact.
Pharma & Biotech
LabGenius-LG Chem deal tests whether AI can improve solid-tumour treatment precision
Discover how LabGenius and LG Chem aim to use AI-designed multispecific antibodies to reduce solid-tumour toxicity and reshape oncology R&D.
Medical Devices & Diagnostics
Can Pearl help Smile Brands turn dental radiographs into a system-wide care advantage?
Find out how Smile Brands’ Pearl dental AI rollout could reshape diagnostic consistency, patient trust and DSO adoption strategy.
Medical Devices & Diagnostics
Why Optellum’s deployment at Tanner Health could matter for lung cancer risk stratification
Find out how Tanner Health’s Optellum rollout could reshape AI lung nodule triage and early lung cancer detection in regional care.
Pharma & Biotech
Could DermaSensor’s NHS study turn AI skin cancer tools into primary care infrastructure?
Find out how DermaSensor’s CE Mark and NHS study could reshape AI-assisted skin cancer assessment across European primary care.
Medical Devices & Diagnostics
Can SOPHiA GENETICS and Memorial Sloan Kettering turn oncology data into a precision medicine engine?
SOPHiA GENETICS and Memorial Sloan Kettering aim to turn cancer data into precision oncology infrastructure. Can the hub deliver?